CYP2B6 516G>T (rs3745274) and smoking status are associated with efavirenz plasma concentration in a Serbian cohort of HIV patients.
about
Pharmacokinetic and Pharmacodynamic Comparison of Once-Daily Efavirenz (400 mg vs. 600 mg) in Treatment-Naïve HIV-Infected Patients: Results of the ENCORE1 Study.CYP2B6*6 and CYP2B6*18 Predict Long-Term Efavirenz Exposure Measured in Hair Samples in HIV-Positive South African WomenComprehensive Pharmacokinetic, Pharmacodynamic and Pharmacogenetic Evaluation of Once-Daily Efavirenz 400 and 600 mg in Treatment-Naïve HIV-Infected Patients at 96 Weeks: Results of the ENCORE1 StudyDevelopment and validation of an LC-MS/MS assay for the quantification of efavirenz in different biological matrices.
P2860
CYP2B6 516G>T (rs3745274) and smoking status are associated with efavirenz plasma concentration in a Serbian cohort of HIV patients.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
CYP2B6 516G>T (rs3745274) and ...... erbian cohort of HIV patients.
@en
CYP2B6 516G>T
@nl
type
label
CYP2B6 516G>T (rs3745274) and ...... erbian cohort of HIV patients.
@en
CYP2B6 516G>T
@nl
prefLabel
CYP2B6 516G>T (rs3745274) and ...... erbian cohort of HIV patients.
@en
CYP2B6 516G>T
@nl
P2093
P50
P1476
CYP2B6 516G>T (rs3745274) and ...... Serbian cohort of HIV patients
@en
P2093
Alieu Amara
Gordana Dragovic
Jovana Kusic
P304
P356
10.1097/FTD.0000000000000098
P577
2014-12-01T00:00:00Z